Christian Staufner

Dr. Christian Staufner

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
RKRobert Kopajtich
Robert Kopajtich
KMKei Murayama
Kei Murayama
AJAndreas R. Janecke
Andreas R. Janecke
THTobias B. Haack
Tobias B. Haack
MBMaximilian Breuer
Maximilian Breuer
CSChristian Staufner
Christian Staufner

7 December 2015 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
CSChristian Staufner
Christian Staufner
MLMartin Lindner
Martin Lindner
CDCarlo Dionisi-Vici
Carlo Dionisi-Vici
PFPeter Freisinger
Peter Freisinger
DDDries Dobbelaere
Dries Dobbelaere
HBHenk J. Blom
Henk J. Blom

1 October 2018 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
DLDominic Lenz
Dominic Lenz
PMPatricia McClean
Patricia McClean
AKAydan Kansu
Aydan Kansu
PBPenelope E. Bonnen
Penelope E. Bonnen
GRGiusy Ranucci
Giusy Ranucci
CSChristian Staufner
Christian Staufner
Biallelic mutations in SCYL1 were recently identified as causing a syndromal disorder characterized by peripheral neuropathy, cerebellar atrophy, ataxia, and recurrent episodes of liver failure. The occurrence of SCYL1 deficiency among patients with previously undetermined infantile cholestasis or acute liver failure has not been studied; furthermore, little is known regarding the hepatic phenotype. We aimed to identify patients with SCYL1 variants within an exome-sequencing study of individuals with infantile cholestasis or acute liver failure of unknown etiology. Deep clinical and biochemical phenotyping plus analysis of liver biopsies and functional studies on fibroblasts were performed. Seven patients from five families with biallelic SCYL1 variants were identified. The main clinical phenotype was recurrent low γ-glutamyl-transferase (GGT) cholestasis or acute liver failure with onset in infancy and a variable neurological phenotype of later onset (CALFAN syndrome). Liver crises were triggered by febrile infections and were transient, but fibrosis developed. Functional studies emphasize that SCYL1 deficiency is linked to impaired intracellular trafficking. SCYL1 deficiency can cause recurrent low-GGT cholestatic liver dysfunction in conjunction with a variable neurological phenotype. Like NBAS deficiency, it is a member of the emerging group of congenital disorders of intracellular trafficking causing hepatopathy.

23 July 2020 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
DLDominic Lenz
Dominic Lenz
DSDesirée E. C. Smith
Desirée E. C. Smith
ECEllen Crushell
Ellen Crushell
RHRalf Husain
Ralf Husain
GSGajja S. Salomons
Gajja S. Salomons
CSChristian Staufner
Christian Staufner

16 November 2023 in Hepatology
Verified
Journal Article
Open access
DLDominic Lenz
Dominic Lenz
LSLea D. Schlieben
Lea D. Schlieben
MSMasaru Shimura
Masaru Shimura
ABAlyssa Bianzano
Alyssa Bianzano
DSDmitrii Smirnov
Dmitrii Smirnov
PHProkisch Holger
Prokisch Holger
Background and Aims: Pediatric acute liver failure (PALF) is a life-threatening condition. In Europe, the main causes are viral infections (12%–16%) and inherited metabolic diseases (14%–28%). Yet, in up to 50% of cases the underlying etiology remains elusive, challenging clinical management, including liver transplantation. We systematically studied indeterminate PALF cases referred for genetic evaluation by whole-exome sequencing (WES), and analyzed phenotypic and biochemical markers, and the diagnostic yield of WES in this condition. Approach and Results: With this international, multicenter observational study, patients (0–18 y) with indeterminate PALF were analyzed by WES. Data on the clinical and biochemical phenotype were retrieved and systematically analyzed. Results: In total, 260 indeterminate PALF patients from 19 countries were recruited between 2011 and 2022, of whom 59 had recurrent PALF. WES established a genetic diagnosis in 37% of cases (97/260). Diagnostic yield was highest in children with PALF in the first year of life (41%), and in children with recurrent acute liver failure (64%). Thirty-six distinct disease genes were identified. Defects in NBAS (n=20), MPV17 (n=8), and DGUOK (n=7) were the most frequent findings. When categorizing, the most frequent were mitochondrial diseases (45%), disorders of vesicular trafficking (28%), and cytosolic aminoacyl-tRNA synthetase deficiencies (10%). One-third of patients had a fatal outcome. Fifty-six patients received liver transplantation. Conclusions: This study elucidates a large contribution of genetic causes in PALF of indeterminate origin with an increasing spectrum of disease entities. The high proportion of diagnosed cases and potential treatment implications argue for exome or in future rapid genome sequencing in PALF diagnostics.

1 May 2020 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
AKA. Kovacevic
A. Kovacevic
SGS.F. Garbade
S.F. Garbade
GHG.F. Hoffmann
G.F. Hoffmann
MGM. Gorenflo
M. Gorenflo
SKS. Kölker
S. Kölker
CSChristian Staufner
Christian Staufner